X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (419) 419
Newspaper Article (174) 174
Magazine Article (53) 53
Publication (11) 11
Patent (6) 6
Book Chapter (3) 3
Conference Proceeding (2) 2
Book / eBook (1) 1
Book Review (1) 1
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (138) 138
index medicus (120) 120
oncology (86) 86
female (80) 80
male (75) 75
middle aged (70) 70
adult (65) 65
clinical neurology (59) 59
aged (55) 55
abstracts (49) 49
brain tumors (40) 40
cancer (37) 37
young adult (33) 33
risk factors (28) 28
tumors (28) 28
aged, 80 and over (26) 26
adolescent (25) 25
quality of life (25) 25
brain neoplasms - therapy (24) 24
medicine & public health (24) 24
research (24) 24
care and treatment (23) 23
symptoms (23) 23
quality-of-life (21) 21
brain neoplasms - pathology (20) 20
glioma (20) 20
neurology (20) 20
analysis (19) 19
prognosis (19) 19
gliomas (18) 18
nursing (17) 17
brain neoplasms - drug therapy (16) 16
glioblastoma (16) 16
treatment outcome (16) 16
brain neoplasms - diagnosis (15) 15
chemotherapy (15) 15
fatigue (15) 15
survival (15) 15
brain cancer (14) 14
child (14) 14
health aspects (14) 14
brain neoplasms - complications (13) 13
clinical trials (13) 13
medicine, general & internal (13) 13
retrospective studies (13) 13
validation (13) 13
abridged index medicus (12) 12
age factors (12) 12
brain neoplasms - genetics (12) 12
cancer-patients (12) 12
ependymoma (12) 12
patients (12) 12
abstracts from the 20th annual scientific meeting of the society for neuro-oncology (11) 11
brain neoplasms - mortality (11) 11
brain neoplasms - psychology (11) 11
brain tumor (11) 11
child, preschool (11) 11
children (11) 11
management (11) 11
newly-diagnosed glioblastoma (11) 11
prognostic-factors (11) 11
radiotherapy (11) 11
risk (11) 11
therapy (11) 11
brain-tumors (10) 10
diagnosis (10) 10
epidemiology (10) 10
follow-up studies (10) 10
genome-wide association (10) 10
neurosciences (10) 10
surgery (10) 10
adjuvant temozolomide (9) 9
central nervous system (9) 9
genomes (9) 9
medical and health sciences (9) 9
medicin och hälsovetenskap (9) 9
patient outcomes (9) 9
polymorphism, single nucleotide (9) 9
seizures (9) 9
surveys and questionnaires (9) 9
brain neoplasms - epidemiology (8) 8
breast-cancer (8) 8
case-control studies (8) 8
clinical investigations (8) 8
combined modality therapy (8) 8
ependymoma - mortality (8) 8
genetic aspects (8) 8
glioma - pathology (8) 8
hospitals (8) 8
medicine (8) 8
sex factors (8) 8
survival analysis (8) 8
survival rate (8) 8
uncertainty (8) 8
united states (8) 8
antineoplastic agents - therapeutic use (7) 7
bevacizumab (7) 7
brain (7) 7
central-nervous-system (7) 7
clinical medicine (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuro-oncology (Charlottesville, Va.), ISSN 1522-8517, 11/2017, Volume 19, Issue suppl_6, pp. vi211 - vi211
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 370, Issue 8, pp. 699 - 708
Journal Article
by Coleman, Robert L and Oza, Amit M and Lorusso, Domenica and Aghajanian, Carol and Oaknin, Ana and Dean, Andrew and Colombo, Nicoletta and Weberpals, Johanne I and Clamp, Andrew and Scambia, Giovanni and Leary, Alexandra and Holloway, Robert W and Gancedo, Margarita Amenedo and Fong, Peter C and Goh, Jeffrey C and O'Malley, David M and Armstrong, Deborah K and Garcia-Donas, Jesus and Swisher, Elizabeth M and Floquet, Anne and Konecny, Gottfried E and McNeish, Iain A and Scott, Clare L and Cameron, Terri and Maloney, Lara and Isaacson, Jeff and Goble, Sandra and Grace, Caroline and Harding, Thomas C and Raponi, Mitch and Sun, James and Lin, Kevin K and Giordano, Heidi and Ledermann, Jonathan A and Buck, M and Dean, A and Friedlander, M L and Goh, J C and Harnett, P and Kichenadasse, G and Scott, C L and Denys, H and Dirix, L and Vergote, I and Elit, L and Ghatage, P and Oza, A M and Plante, M and Provencher, D and Weberpals, J I and Welch, S and Floquet, A and Gladieff, L and Joly, F and Leary, A and Lortholary, A and Lotz, J and Medioni, J and Tredan, O and You, B and El-Balat, A and Hänle, C and Krabisch, P and Neunhöffer, T and Pölcher, M and Wimberger, P and Amit, A and Kovel, S and Leviov, M and Safra, T and Shapira-Frommer, R and Stemmer, S and Bologna, A and Colombo, N and Lorusso, D and Pignata, S and Sabbatini, R F and Scambia, G and Tamberi, S and Zamagni, C and Fong, P C and O'Donnell, A and Gancedo, M Amenedo and Herraez, A Casado and Garcia-Donas, J and Guerra, E M and Oaknin, A and Palacio, I and Romero, I and Sanchez, A and Banerjee, S N and Clamp, A and Drew, Y and Gabra, H G and Jackson, D and Ledermann, J A and McNeish, I A and Parkinson, C and Powell, M and Aghajanian, C and ... and ARIEL3 investigators and ARIEL3 Investigators
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 390, Issue 10106, pp. 1949 - 1961
Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a BRCA mutation or high percentage of... 
MEDICINE, GENERAL & INTERNAL | MULTICENTER | SOLID TUMORS | BEVACIZUMAB | OPEN-LABEL | CANCER | HETEROZYGOSITY | EPITHELIAL OVARIAN | CHEMOTHERAPY | Double-Blind Method | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Survival Rate | Treatment Outcome | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Indoles - administration & dosage | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Maintenance Chemotherapy - methods | Internationality | Ovarian Neoplasms - therapy | Female | Aged | Molecular Targeted Therapy - methods | Clinical trials | Care and treatment | Carcinoma | Drug therapy | Ovarian cancer | Cancer | Analysis | Chemotherapy | Ovarian carcinoma | Platinum | Biomarkers | Mutation | Cancer therapies | Evidence-based medicine | Tumors | Homologous recombination | Central nervous system | Poly(ADP-ribose) | Homology | Genomes | Fallopian tube | Anticancer properties | Metastases | Homologous recombination repair | Randomization | Pain | Motivation | Ribose | Hemoglobin | Alanine | Anemia | Poly(ADP-ribose) polymerase | Adenosine diphosphate | Breast cancer | Patients | Survival | Heterozygosity | Abdomen | Polymerase | Inhibitors | Point mutation | Loss of heterozygosity | Antitumor activity | Aspartate aminotransferase | Peritoneum
Journal Article
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 5/2012, Volume 123, Issue 5, pp. 727 - 738
Journal Article
Cancer cell, ISSN 1535-6108, 2015, Volume 27, Issue 5, pp. 728 - 743
Journal Article
Neuro-Oncology, ISSN 1522-8517, 11/2018, Volume 20, Issue suppl_7, pp. vii4 - vii5
Journal Article
Journal Article
Neuro-oncology (Charlottesville, Va.), ISSN 1522-8517, 11/2017, Volume 19, Issue suppl_6, pp. vi203 - vi204
Journal Article
Nature, ISSN 0028-0836, 09/2018, Volume 561, Issue 7724, pp. S45 - S45
Journal Article
Journal Article